Articles related to GUIDELINES/RECOMMENDATIONS

Effective management of tardive dyskinesia requires early prevention with second-generation antipsychotics and the use of VMAT2 inhibitors like deutetrabenazine and valbenazine, which offer the highest quality evidence for reducing symptoms.

Measuring exhaled nitric oxide (FeNO) aids in diagnosing asthma, predicting response to corticosteroids, and monitoring treatment adherence, making it a valuable adjunctive tool in comprehensive asthma management.

The updated anaphylaxis guidelines emphasize immediate epinephrine administration at the onset of symptoms and provide comprehensive recommendations for monitoring and follow-up care to prevent recurrence and improve patient education.

Early targeted palliative care consultations in the ICU can significantly increase transitions to do-not-resuscitate orders and reduce the duration of mechanical ventilation, enhancing end-of-life care.

The new guideline emphasizes early intervention and careful medication selection for pregnant patients with epilepsy, recommending lamotrigine, levetiracetam, and oxcarbazepine, while advising against valproic acid, phenobarbital, and topiramate.

The AGS Beers Criteria highlights medications that pose significant risks to the elderly, such as growth hormones and certain antidepressants, guiding physicians towards safer prescribing practices.